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Background: Serin protease inhibitor ‘‘Ka-
zal type 5’’ (SPINK5, LEKTI) gene is
located on chromosome 5q31-32 region.
Interestingly, this region contains the so
called cytokine cluster including IL-4, IL-5,
IL-9 and IL-13. Up to now, 32 single
nucleotide polymorphisms have been identi-
fied on SPINK5 gene. In several studies it
has been shown that G1258A (Glu420Lys)
substitution is associated with atopy, atopic
dermatitis, high levels of serum IgE and
asthma.
Aim: This study aimed to determine the
reletionship of (Glu420Lys) substitution in
SPINK5 gene with asthma and asthma
phenotypes in Turkish children.
Methods: The frequency of G1258A
(Glu420Lys) polymorphism was investi-
gated by PCR-RFLP analysis using Hinf I
restriction endonuclease in 291 asthmatic
children and 215 healthy controls. Allele
frequencies of G1258A polymorphism were
compared between asthmatic and healthy
cohorts. Association between the poly-
morphism and asthma phenotypes including
eosinophil counts, total IgE and FEV1 were
analysed.
Results: SPINK5 mutant genotype was sig-
nificantly more frequent in asthmatic chil-
dren (0.333) compared to healthy controls
(0.242) (P5 0.026) in a model where the
wild type G allele is taken as the dominant
allele. Glu420Lys genotype did not show
any significant association with asthma
phenotypes.
Conclusion: These results suggest that
Glu420Lys amino acid changes at SPINK5
gene may be a risk factor for asthma in this
population.
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Introduction: Asthma and rhinitis is a com-
plex disorder which is known to be affected
by interactions between genetic and envir-
onmental factors. NOS (nitric oxide
synthase) influences the production of in-
nate NO (nitric oxide) that could participate
the inflammatory response and represent a
key mechanism in asthma.
Methods: The aim of the study was to
investigate the polymorphisms of AAT
repeats in intron 20, CA repeats in exon 29
and GT repeats in intron 2 of the NOS1
gene in asthmatic and rhinitis children in
Taiwan, and their interactions with environ-
mental factors. One hundred and fifty-five
asthmatic children, 115 rhinitis children and
186 control children aged 5 to 12 years were
recruited in southern Taiwan. In the present
study, we addressed genetic effects of NOS 1
gene and interaction effects with environ-
mental factors on childhood asthma and
rhinitis.
Results: After adjusting for age, sex and
potential confounders, only NOS1 gene with
14/14 AAT tandem repeats was significantly
associated with asthmatic children (AOR5
3.17, P5 0.022). The interaction effects
between NOS1 14/14 AAT and molds,
cockroaches, phadiatop test and high levels
of total IgE were from 3.6 to 17.9 folds on
asthmatic children. But we did not find the
relationship between NOS1 gene and rhinitis.
Conclusions: This study findings provide
strong evidence that NOS1 gene with 14/14
AAT tandem repeats has a significantly
effect on asthmatic children, and also have
interaction effects with environmental fac-
tors.
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Background: The allergic disease has multi-
factorial aetiology. The interaction of genet-
ic and environmental agents induces parti-
cularities in the clinical expression of the
respiratory allergy.
Objective: To analyse the clinical patterns
of respiratory allergy in pairs of siblings.
Methods: It was included 18 pairs of sib-
lings observed in our allergy department.
We analysed the clinical allergy patterns
concerning respiratory presentation (bron-
chial asthma (BA) and/or allergic rhinitis
(AR) and/or conjunctivitis (C) and/or atopic
dermatitis (AD)), its age of b eginning and
BA and AR severity. We denominated
‘‘homogeneous’’ when the clinical presenta-
tion was similar in both siblings of each pair
and ‘‘heterogeneous’’ when the clinical
presentation was different. The clinical
patterns were compared in each pair of
siblings (1st and 2nd brother).
Results:
We observed that 6 pairs showed homo-
geneous clinical pattern characterized by BA
and AR. Furthermore, in 5 pairs, both
siblings presented the same severity of BA
and AR. The first manifestation was equal
in 4 pairs. Also 4 pairs have a family
background of allergy. All of them were
house dust mites (HDM) sensitised. Twelve
pairs of siblings presented heterogeneous
clinical pattern. In each pair, besides the
different clinical presentation we also
founded discrepancy in the 1st manifesta-
tion and clinical severity. Half of them had a
family background of allergy. In 10 pairs,
both siblings were HDM sensitised. The
results concerning age (current age, 1st
consult and beginning of each symptom) in
the total group and sub-groups according to



















Total 18 17.17 5.9 13.17 4.3 6.47 5.3 6.67 5.3 8.27 4.6 12.57 3.8 3.47 6.5
1st – 19.07 6.1 13.67 4.4 7.37 5.8 8.37 5.5 9.07 4.2 11.67 5.0 4.77 5.1
2nd – 15.37 5.2 12.57 4.3 5.47 4.6 4.27 3.7 7.47 4.9 12.77 3.2 0.77 0.3
Homogeneous clinical pattern: total 6 17.27 7.8 12.27 4.6 4.77 4.4 4.77 4.4 6.77 3.9 – –
Homogeneous clinical pattern: 1st – 20.57 7.3 13.17 2.9 6.17 5.6 6.17 5.6 8.57 3.3 – –
Homogeneous clinical pattern: 2nd – 14.07 7.5 11.37 6.0 3.47 2.4 3.47 2.4 5.07 3.8 – –
Heterogeneous clinical pattern: total 12 17.17 4.8 13.57 4.2 7.27 5.5 7.77 5.4 9.07 4.8 12.17 4.1 3.97 4.8
Heterogeneous clinical pattern: 1st – 18.27 5.6 13.97 5.1 8.07 6.0 9.47 5.3 9.37 4.8 11.67 5.0 4.77 5.1
Heterogeneous clinical pattern: 2nd – 16.07 3.8 13.17 3.4 6.47 5.2 4.97 4.6 8.87 5.0 12.77 3.2 0.77 0.3
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the clinical pattern are presented in the
table.
Conclusions: The age of the beginning of the
symptoms and the need of an allergy consult
was earlier in the 2nd sibling. In the group of
siblings with homogeneous clinical pattern
characterized by HDM allergic BA and AR,
the symptoms began at a pre-school age. In
the heterogeneous group, the 1st clinical
manifestation was at a school age. Determi-
nant genetic agents must be underlying in
the group of siblings with homogeneous
clinical pattern.
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Introduction: Chemokines, such as eotaxin1,
eotaxin2, RANTES, MCP provoke an
eosinophilic response in the peripheral
blood and airways via CCR3. CCR3 gene
SNPs and Eotaxin gene SNPs already
reported to be associated with asthma. We
would search for the evidence of genetic
interaction to blood eosinophilia among
SNPs of Eotaxin genes and CCR3 gene in
asthma.
Methods: Five hundred and thirty-three
asthmatics were enrolled. Asthmatics with
eosinophilia (40.5 109/L) were compared
with those without eosinophilia (o
0.5 109/L). The interactions were tested
with two different methods. Chi-square tests
were used to compare SNP frequencies.
Another interaction model was built with
logistic regression.
Results: Eotaxin21 304C4A (29L4I) was
significantly associated with three of four
CCR3 SNPs in asthma with eosinophilia.
(P5 0.037B0.009) Eotaxin21 304C4A
(29L4I) with CCR3 SNPs effect was also
significantly associated with blood eosino-
philia in a interaction model constructed
with logistic regression. (P5 0.0087)
Conclusions: This statistical model can
probably be one of the evidence that
CCR3 and Eotaxin genes interact to the
blood eosinophilila in asthma.
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Introduction: Values of exhaled nitric oxide
(FENO) are variable, even in healthy sub-
jects. This variation can be attributed to
some variables, as age, height, weight and
body mass index (BMI).
Objectives: To evaluate the relationship
between FENO and age, height, weight
and BIM in asthmatic patients younger than
18 years old.
Material and methods: During a 2 week
period, 86 consecutive asthmatic patients
younger than 18 years old, followed in our
outpatient clinic, were submitted to a FENO
determination (flow rate: 50mL/sec). We
recorded their age, height and weight. The
body mass index (BMI) was calculated. We
analyzed the relationship between FENO
and age, height, weight and BMI.
Results: The mean age was 12.3 years old
(SD 3.6), with 68.6% males. The median
value for FENO, height, weight and BMI
was 16ppb (P25-755 12.8–64,3 ppb), 153 cm
(P25-755 136–166 cm), 49Kg (P25-755 34–
61Kg) and 20.5 (P25-755 17.5–23.5). Sta-
tistical significative correlations were found
between FENO and height (0.648), weight
(0.602), age (0.582) and BMI (0.424).
Discussion and conclusion: As in healthy
subjects, a correlation between FENO and
age, weight, height and BMI was found in
our asthmatic population. This could be due
to the same reasons pointed for healthy
people.
1668
The effects of emotions and stress on
pulmonary function in asthmatic pacients
Iamandescu, I1; Onogea, M2
1Colentina Hospital, Allergology Dept., Bucharest,
Romania, 2Colentina Hospital, Internal Medicine Dept.,
Bucharest, Romania
Objectives: Clinical observations suggest
that both positive and negative stress can
precipitate asthmatic symptoms, but there
isn’t enough experimental evidence regard-
ing the link between the specificity of
emotions (inducing either active or passive
coping) and bronchial diameter (constrictive
and dilatatory modifications). In this paper
we studied the impact of different emotional
states and types of stress on respiratory
resistence in asthmatic and nonasthmatic
individuals.
Methods: Participants (25 asthmatic and 25
nonasthmatic patients) viewed short film
sequences selected to induce anxiety, anger,
sadness, surprise, amusement, and com-
pleted two stressful tasks: mental arithmetic
to induce active coping efforts and viewing
of medical films to induce passive coping
efforts. Peak Expiratory Flow (PEF), heart
rate, and self-reported affective states were
measured throughout the experimental ses-
sion.
Results: Decreases (between 4–12%) in PEF
were found in all emotional states compared
with the neutral state, asthmatic patients
showing stronger reactions to the films than
healthy control subjects. The experimental
studies inducing passive coping have gener-
ated PEF decreases in most subjects who
viewed a medical (surgery operations) film
and violent (drama) short film sequences
(both in 88% astmatics). Even in the case of
positive emotions (using a funny short
movie with Mr. Bean) PEF decreased with
4–9% in 76% of the subjects. The active
coping induced by mental arithmetic have
decreased PEF in 75% subjects but only
with 4–7%. Also, significant increases in
heart rate and self-reported affective states,
sadness, amusement and dyspnea were
detected.
Conclusions: Various emotional states and
types of stress increase respiratory resistan-
ce(measured by PEF) but may be possible
that the intensity of these modifications
could decisively depend on the degree of
emotional involvement of the subjects and
the severity of bronchial inflammations
during the experiment as shown by our
own previous study (Iamandescu-1980).
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Both incidences of asthma and obesity are
increasing worldwide. Age, usage of inhaled
and oral corticosteroids are risk factors for
osteoporosis for asthmatic patients in post-
menopausal stage. In our study we aimed to
find out the incidence of osteoporosis in our
asthmatic patients and compare them with
control groups. Then we investigated the
effect of asthma related parameters and
influence of obesity to osteoporosis. Forty-
six patients (diagnosed as asthma according
to GINA criteria) and 75 age matched
postmenopausal women included to the
study. Weight and height were measured
and body mass index (BMI) was calculated.
Bone mineral density (BMD) of total body,
lumbar spine and femoral neck was mea-
sured by dual-energy X-ray absorptiometry.
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